BRAND REPORT FOR THE 6 MONTH PERIOD ENDED DECEMBER 2016

Transcription

1 BRAND REPORT FOR THE 6 MONTH PERIOD ENDED DECEMBER 2016 No attempt has been made to rank the information contained in this report in order of importance, since BPA Worldwide believes this is a judgment which must be made by the user of the report. Racher Press Inc. 220 Fifth Avenue Tel.: (212) Fax: (212) CHAIN DRUG REVIEW, published 19 times a year, is a bi-weekly B2B news publication serving the multi-billion chain drugstore industry. Distributed to headquarter executives and chain drug pharmacists, Chain Drug Review provides its readers with a unique perspective and commentary on all the latest news and trends impacting community pharmacy today. In addition to the news, Chain Drug Review delves into and examines the merchandising aspect of virtually every product category sold in the chain drug store BRAND REPORT PURPOSE The Brand Report provides a deeper understanding and identification of all audited touch points with customers that have interest in the brand. It is designed to present analysis of all communication channels, including a brand s unique users within each channel of, but not across, multiple media platforms. This non-integrated report contains data for each separate media channel as indicated in the Executive Summary. No attempt has been made to identify or eliminate duplication that may exist across media channels. CHANNELS CHAIN DRUG REVIEW MAGAZINE CHAIN DRUG REVIEW E-NEWSLETTER CHAIN DRUG REVIEW WEBSITE 9 Issues in the period 40,200average circulation 36 issued in the period 13,960 average per occurrence 15,914 average unique browsers EXECUTIVE SUMMARY Below are the Average contacts per occurrence, including frequency per period reported Non-Paid Paid Average CHAIN DRUG REVIEW MAGAZINE Unique Total* (9 issues in the period) 40, ,200 a. Print 40, ,200 b. Digital 5, , Requested 5, ,887 THE CRITERION 2. Non Requested SOCIAL MEDIA CHAIN DRUG REVIEW E-NEWSLETTER (36 issued in the period) 13,960-13,960 CHAIN DRUG REVIEW WEBSITE (Monthly Unique Browsers with 35,526 average Page Impressions) *Unique Total represents unique recipients, not the sum of Print and Digital. 15,914-15,914 No attempt has been made to identify or eliminate duplication that may exist across media channels.

2 MAGAZINE CHANNEL Official Publication of: None/Established: 1978/Issues Per Year: 19 (See Additional Data) FIELD SERVED CHAIN DRUG REVIEW serves the Chain Drug industry including Drug Chains and Franchises, Supermarkets/Discounts, Wholesalers, On-Line Retailers and their headquarters; Associations/Government Agencies; Manufacturer s Reps; and Others allied to the field. DEFINITION OF RECIPIENT QUALIFICATION Qualified recipients include President/CEO/Owner/Chairman, VP/Director/GM/Other, Buyer/Category Manager/Merchandiser, District/Regional Manager, Pharmacy Manager, Pharmacist, Pharmacy Technician and Others Allied to the Field including Paid Subscribers. AVERAGE NON-QUALIFIED CIRCULATION NON-QUALIFIED Not Included Elsewhere Copies Other Paid Circulation 101 Advertiser and Agency 1,596 Allocated for Trade Shows and Conventions 378 All Other 36,876 TOTAL 38, AVERAGE QUALIFIED CIRCULATION BREAKOUT FOR PERIOD Total Qualified Qualified Non-Paid Qualified Paid QUALIFIED CIRCULATION Copies Percent Copies Percent Copies Percent Individual 40, , Sponsored Individually Addressed Membership Benefit Multi Copy Same Addressee Single Copy Sales TOTAL QUALIFIED 40, , CIRCULATION 2. QUALIFIED CIRCULATION BY ISSUES FOR PERIOD Unique Total 2016 Issue Print Digital Qualified* July 25 40,200 4,209 40,200 August 8 40,200 4,200 40,200 September 12 40,200 4,158 40,200 September 26 40,200 7,014 40,200 October 10 40,200 6,994 40,200 October 24 40,200 6,732 40,200 November 7 40,200 6,688 40,200 *November 21 40,200 6,627 40,200 December 12 40,200 6,360 40,200 *Unique Total Qualified represents unique recipients, not the sum of Print and Digital. **Analyzed Issue 3a. BUSINESS/OCCUPATION BREAKOUT OF QUALIFIED CIRCULATION FOR ISSUE OF NOVEMBER 21, 2016 This issue is equal to the average of the other 8 issues reported in Paragraph 2. UNIQUE TOTAL BUSINESS AND INDUSTRY QUALIFIED* PERCENT OF TOTAL Print Digital Drug Chain, Drug Franchise, Supermarket/Discount, Wholesaler, and On-line Retailer and their headquarters. (Note 1) 15, ,523 4,633 Pharmacies in Drug Chains, Drug Franchises, and Supermarkets/Discounts. (Note 2) 24, ,450 1,885 c. Other Businesses including Associations/Government Agencies and Manufacturer s Rep. (Note 3) UNIQUE TOTAL QUALIFIED CIRCULATION* 40, ,200 6,627 PERCENT *Unique Total Qualified represents unique recipients, not the sum of Print and Digital. Note 1: Includes Pres/CEO/Owner/Chairman, VP/Dir/GM/Other, Buyer/Category Mgr./Merchandiser, District/Regional Mgr., and Other titled personnel not elsewhere classified. Note 2: Includes Pharmacy Managers, Pharmacists, and Pharmacy Technicians. Note 3: Includes paid subscribers 3b. QUALIFICATION SOURCE BREAKOUT OF QUALIFIED CIRCULATION FOR ISSUE OF NOVEMBER 21, 2016 Qualified Within QUALIFICATION SOURCE 1 Year 2 Years 3 Years Print Digital Unique Total Qualified* Percent I. Direct Request: 29,913 10,287-40,200 6,627 40, II. Request from recipient s company: III. Membership Benefit: IV. Communication from recipient or recipient s company (other than request): V. TOTAL Sources other than above (listed alphabetically): Association rosters and directories Business directories Manufacturer s, distributor s, and wholesaler s lists Other sources VI. Single Copy Sales: UNIQUE TOTAL QUALIFIED CIRCULATION* 29,913 10,287-40,200 6,627 40, PERCENT *Unique Total Qualified represents unique recipients, not the sum of Print and Digital. 3c. MAILING ADDRESS BREAKOUT OF QUALIFIED CIRCULATION FOR ISSUE OF NOVEMBER 21, 2016 MAILING ADDRESS Print Digital Unique Total Qualified* Percent Individuals by name and title and/or function 40,186 6,624 40, Individuals by name only Titles or functions only Company names only Multi-Copy Same Addressee copies Single Copy Sales UNIQUE TOTAL QUALIFIED CIRCULATION* 40,200 6,627 40, *Unique Total Qualified represents unique recipients, not the sum of Print and Digital. No attempt has been made to identify or eliminate duplication that may exist across media channels. CHAIN DRUG REVIEW / December

3 AVERAGE ANNUAL AUDITED QUALIFIED CIRCULATION AND CURRENT UNAUDITED CIRCULATION STATEMENTS Audited Data Audited Data Audited Data Audited Data Audited Data Circulation Claim 6-Month Period Ended: January June 2014 July December 2014 January June 2015 July December 2015 January June 2016 July December 2016* Unique Total Audit Average Qualified***: 40,161 40,200 40,200 40,200 40,200 40,200 Unique Qualified Non-Paid Total***: 40,099 40,139 40,143 40,147 40,152 40,160 Print: 40,099 40,139 40,143 40,147 40,152 40,160 Digital: - - 7,695 5,062 4,789 5,877 Unique Qualified Paid Total***: Print: Digital: Post Expire Copies in Total Qualified Circulation: **NC **NC **NC **NC **NC **NC Average Annual Order Price: **NC **NC **NC **NC **NC **NC *NOTE: July December 2016 data is unaudited. With each successive period, new data will be added until six 6-month periods are displayed. **NC = None Claimed. ***Unique Total Qualified represents unique recipients, not the sum of Print and Digital. GEOGRAPHICAL BREAKOUT OF QUALIFIED CIRCULATION FOR ISSUE OF NOVEMBER 21, 2016** Unique Total State Print Digital Qualified* Percent Maine New Hampshire Vermont Massachusetts 1, ,012 Rhode Island Connecticut NEW ENGLAND 2, , New York 2, ,669 New Jersey Pennsylvania 1,177 2, ,177 2,462 MIDDLE ATLANTIC 6, , Ohio 2, ,089 Indiana Illinois 878 1, ,629 Michigan 1, ,430 Wisconsin EAST NO. CENTRAL 6,723 1,147 6, Minnesota Iowa Missouri North Dakota South Dakota Nebraska Kansas WEST NO. CENTRAL 2, , Delaware Maryland Washington, DC Virginia 1, ,140 West Virginia North Carolina 403 1, ,434 South Carolina Georgia Florida 1,320 2, ,320 2,431 SOUTH ATLANTIC 8, , *Unique Total Qualified represents unique recipients, not the sum of Print and Digital. **See Additional Data State Print Digital Qualified* Percent Kentucky Tennessee Alabama Mississippi EAST SO. CENTRAL 2, , Arkansas Louisiana Oklahoma Texas 2, ,070 WEST SO. CENTRAL 3, , Montana Idaho Wyoming Colorado New Mexico Arizona Utah Nevada MOUNTAIN 2, , Alaska Washington 32 1, ,010 Oregon California Hawaii 2, , PACIFIC 3, , UNITED STATES 38,929 6,092 38, U.S. Territories Canada Mexico 1, ,241 - Other International APO/FPO UNIQUE TOTAL QUALIFIED CIRCULATION* Unique Total 40,200 6,627 40, E-NEWSLETTER CHANNEL 2016 Chain Drug Review E-Newsletter JULY July 6 13,091 July 20 13,115 July 25 13,118 July 28 13,113 AUGUST August 2 13,105 August 3 13,105 August 6 13,050 August 7 13,046 August 8 13,041 August 11 12,760 August 17 12,721 August 22 12,695 August 25 12,678 August 29 12,711 August 30 12,701 SEPTEMBER September 6 12,681 September 8 12,646 September 22 15,495 September 26 15,434 Chain Drug Review E-Newsletter (36 issued in the period) SOCIAL MEDIA CHANNEL 2016 Chain Drug Review E-Newsletter OCTOBER October 5 15,320 October 17 15,254 October 19 15,226 October 20 15,229 NOVEMBER November 4 15,017 November 7 14,992 November 8 14,962 November 15 14,972 November 21 14,703 November 28 14,612 November 29 14,607 DECEMBER December 7 14,561 December 14 14,569 December 16 14,552 December 20 14,565 December 22 14,564 December 29 14,537 AVERAGE: 13,960 No attempt has been made to identify or eliminate duplication that may exist across media channels. CHAIN DRUG REVIEW / December

4 WEBSITE CHANNEL PAGE IMPRESSIONS USER SESSIONS UNIQUE BROWSERS UNIQUE BROWSER FREQUENCY PAGE DURATION USER SESSION DURATION July 31,325 15,378 11, :38 01:42 August 41,537 20,089 14, :48 01:55 September 36,717 18,856 14, :45 01:40 October 33,892 23,134 18, :48 00:50 November 34,591 23,172 18, :54 00:56 December 35,099 22,822 18, :42 00:55 AVERAGE: 35,526 20,575 15, :45 01:19 July December 2016 data was provided by Google Analytics. All website activity is audited by BPA Worldwide. WEBSITE GLOSSARY Page Impressions: A Page Impression is recorded each time a page implanted with the JavaScript code (tag) is displayed in a browser window. This will occur whether the page is served directly from the web server, from a proxy, or from the browser s cache. User Sessions: A single continuous set of activity attributable to a cookied browser resulting in one or more pulled text and/or graphics downloads from a site. A period of 30 minutes of inactivity will terminate the session. Unique Browsers: An identified and unduplicated Cookied Browser that accesses Internet content or advertising during a measurement period. Unique Browser Frequency: Unique Browser Frequency represents the average number of times a Unique Browser visits a site during a reporting period. This is calculated by dividing the total number of User Sessions by the number of Unique Browsers. Page Duration: The average time spent viewing any page on a web site. User Session Duration: The average time visitors remain on a site per session. For info on how to obtain online ad campaign performance metrics across multiple sites, visit ADDITIONAL DATA METHOD OF DISTRIBUTION: All qualified circulation conforms to the field served and definition of recipient's qualification, as reported. Print copies are distributed via postal services or other carriers. Recipients of the digital version are notified via when the version is available. STATEMENT OF CONTENT PLATFORM: Editorial Replica- If a print edition exists, editorial and design are unchanged from the original print edition. Each issue's content and design are identical to the original edition. Apart from minor updates, the content cannot be changed once the issue is made available. MAGAZINE: CHANGE IN FREQUENCY: Effective with the July 25, 2016 issue, Chain Drug Review changed its frequency from 20 to 19 issues per year. GEOGRAPHIC DISTRIBUTION: Geographic data for E-Newsletter and Website are not reported at the media owner s option. PUBLISHER S AFFIDAVIT We hereby make oath and say that all data set forth in this statement are true. Susan Schinitsky, Publisher Pamela Vandernoth, Circulation Manager (At least one of the above signatures must be that of an officer of the publishing company or its authorized representative.) IMPORTANT NOTE: This unaudited brand report has been checked against the previous audit report. It will be included in the annual audit made by BPA Worldwide. Date signed January 5, 2017 State New York County New York Received by BPA Worldwide January 5, 2017 Type BJ ID Number C038B0D6 About BPA Worldwide: A not-for-profit organization since 1931, BPA Worldwide is governed by a tripartite board comprised of media owners, advertising agencies and advertisers. Headquartered in Shelton, Connecticut, USA, BPA has the largest membership of any media-auditing organization in the world, spanning more than 30 countries. Globally, BPA audits media properties including consumer magazines, newspapers, web sites, events, newsletters, databases, wireless, social media and other advertiser-supported media as well as advertiser and agency members. Visit for the latest audit reports, membership information and publishing and advertising industry news. Recycled Paper Copyright 2016 BPA Worldwide. All rights reserved. CHAIN DRUG REVIEW / December 2016

5 chain drug review 2017 print rates (GROSS) chain drug Four-Color Units 1-2x 3-5x 6-11x 12-23x 24-35x 36x Full page $11,766 $10,648 $8,820 $7,650 $7,226 $6,995 Standard Page $8,425 $7,750 $7,282 $6,814 $6,382 $6,139 Half-Page Horizontal $7,059 $6,706 $5,795 $5,229 $5,117 $4,935 3 Column $6,895 $6,365 $5,572 $5,148 $5,042 $4,773 2 Column $4,442 $4,097 $3,581 $3,306 $3,237 $2,865 1 Column $3,619 $3,198 $2,766 $2,409 $2,352 $2,273 1/3 Page $3,529 $3,176 $2,646 $2,364 $2,294 $2,117 Spread Rates 1-2x 3-5x 6-11x 12-23x 24-35x 36x Full page $18,766 $17,566 $14,944 $13,005 $12,283 $11,892 Standard Page $14,323 $13,175 $12,275 $11,584 $10,849 $10,436 Half-Page Horizontal $12,003 $11,400 $9,852 $9,161 $8,699 $8,390 Premium Positions Rate Full Front Cover Position $23,530 PUBLISHER RESERVES THE RIGHT TO CHANGE RATES UPON NINETY (90) DAYS NOTICE. 3-Page Gatefold $29,500 PRINT ADVERTISING CONDITIONS AND TERMS AGENCY COMMISSION/ PAYMENT TERMS 15% of gross billing to agencies if paid within 30 days. Mechanical and production charges noncommissionable. Publisher reserves the right to hold advertiser and/or its agency jointly and severally liable for monies as are due and payable to the publisher. FREQUENCY RATES: Number of insertions used by an advertiser within 12 months from date of first insertion of contract period determines frequency rate. Combined frequency discounts apply to space run in CHAIN DRUG REVIEW and MMR. CANCELLATIONS No cancellations accepted after closing date. Front cover position and gatefolds: Noncancellable. Creative subject to publisher s approval. SHORT RATE: All advertising subject to short rate when less advertising than specified by original order is run. PRODUCTION CHARGES: All ad work subject to additional production charges. There will be a minimum charge of $75 for supplied advertisements that require resizing or the conversion of images to CMYK. INSERTS: If supplied by advertiser completely printed on two sides, earned black-and-white space rate applies. Maximum weight: 80 lbs. Offset, 25 x 38 basis, without premium. Before preparing, contact production manager for mechanical requirements and postal regulations. Contact sales manager for pricing on supplied inserts.

6 2016 print rates chain drug review 2017 print specifications Print Advertising Specifications Printing process: Printed web-offset. Saddle stitched. Publication trim size: 10 7 /16 x 13 3 /4 Live area: 9 11 /16 x 12 3 /4 Bleed: /16 x 14 Space units: 5 Columns/page 1 Column: /16 2 Columns: 3 3 /4 3 Columns: 5 11 /16 4 Columns: 7 5 /8 5 Columns: 9 13 /16 For front cover ad and gatefold specs, contact Chain Drug Review production manager, Peggy Navarre at: (212) or pnavarre@racherpress.com Ad Sizes in gutter Full Page Spread Bleed: 21 1 /8 x 14 Trim Size: 21 7 /8 x 13 3 /4 Live Area: 20 1 /8 x 12 3 /4 Full Page Bleed: /16 x 14 Trim Size: 10 7 /16 x 13 3 /4 Live Area: 9 11 /16 x 12 3 /4 Full Page Non-bleed: 9 11 /16 x 12 3 /4 Half Page Spread Bleed: 21 1 /8 x 7 trim size: 20 7 /8 x 6 5 /8 live area: 20 1 /8 x 6 1 /2 Standard Page: 7 5 /8 x 10 Half Page Horiz: 9 11 /16 x 7 3 columns: 5 11 /12 x 12 2 columns: 3 3 /4 x 12 3 /4 1 column: 3 13 /16 x 12'' 1/3: 3 3 /4 x 8 1/4: 5 11 /16 x 6 Submission of Ad Materials Only digital ad files are accepted. Files must be furnished as a high resolution (300 dpi), pdf x1a file. Contact production manager for further information regarding special circumstances where other software might be accepted. A proof of file at 100% of unit size must accompany all digital files. All files must contain customer name, publication name and issue date and file name. All 4-color files must be in CMYK mode. If there is a Pantone or 5th color arrangements must be made with publication production manager. 4-color scans must be converted from RGB to CMYK. Resolution must be 300 dpi at 100% size to ensure proper reproductions. ADVERTISERS: Questions regarding the transfer of advertsing electronically can be directed to the Production Manager, Paggy Navarre. Peggy Navarre, Production Manager Racher Press, 220 Fifth Avenue, 18th fl. Tel: (212) pnavarre@racherpress.com MOST REPEATED MISTAKES 1. Bleed Not Included 2. File is Not CMYK 3. File is Not Hi-res pdf

7 2016 print rates chain drug review 2017 digital rates (GROSS)& specs Website Advertising: Ad sizes: Acceptable Formats JPG or GIF All art files (graphic and link URL) should be sent to: Bill Buckley at or For more information, contact: Kevin Burke, Vice President, Group Advertising Director or Welcome Mat ad opens on first page load. It will disappear after 15 seconds or when close button is clicked. ALL DIGITAL FILES SHOULD BE ACCOMPANIED BY A LINK OR LANDING PAGE URL Welcome Mat 640 x 640 / $3,250 Leaderboard, (top) 1170 x 120 / $1,800 Sidebar Rectangle 336 x 300 / $1,200 Sidebar Skyscraper 336 x 600 / $1,500 Leaderboard (homepage, left) 728 x 90 / $1,100 Leaderboard (bottom, left) 728 x 90 / $300 Footer ads 190 x 80 / $300 Breaking News Sponsorship: Chain Drug Review e-newsbreak Chain Drug Review s e-newsbreaks are timely news alerts sent to Chain Drug Review s subscriber base only when significant industry news occurs, therefore CDR cannot provide advance notice of date and time that an e-newsbreak will be deployed. Banner Size : 558 x 90 Acceptable format: GIF or JPG Send banner and link URL to: Bill Buckley, bbuckley@racherpress.com enewsbreak BREAKING NEWS: Sept. 22, 2016 Rite Aid Reports Declined 2Q Earnings, Retail Sales Despite an uptick in total sales, lower drug reimbursement rates and script count trimmed profits at Rite Aid Corp. for its fiscal 2017 second quarter. The company also said it continues to expect its acquisition by Walgreens Boots Alliance Inc. to close by the end of 2016, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatemcitationem ullam. Pricing for e-newsbreak Banner Ad (NET) FREQUENCY RATE PER BLAST 1-3 times $1, times $ times $ times $650

8 2016 print rates chain drug review 2017 contact information Advertising Sales Kevin Burke Vice President/Group Advertising Director 220 Fifth Ave., 18th Floor Tel: , Fax: Northeast Region: Andrea Fallin Northeast Sales Director 220 5th Ave., 18th floor New York, NY, Tel: FX: Southeast Region: Rick Kolinsky Director of Sales 220 Fifth Ave., 18th floor Tel: Cell: Fax: Midwest/Western Region: Christopher Stanton Director of Sales 1005 Sweetgrass Lane Austin, TX Tel: Cell: Fax: Peggy Navarre Production Director Chain Drug Review 220 Fifth Ave., 18th Floor Tel: Fax: Main Office: Racher Press, Inc th Avenue, 18th floor New York, New York Austin, Texas Office: Chain Drug Review 1005 Sweetgrass Lane Austin, Texas